[go: up one dir, main page]

Francavilla et al., 1988 - Google Patents

Regulation of liver size and regeneration: importance in liver transplantation

Francavilla et al., 1988

View HTML
Document ID
10762539006308823341
Author
Francavilla A
Ove P
Polimeno L
Coetzee M
Makowka L
Barone M
Van Thiel D
Starzl T
Publication year
Publication venue
Transplantation proceedings

External Links

Snippet

Table 1 indicates the two types of factors controlling normal liver physiology. It is very difficult to define the exact role of each of these factors because they are very closely interrelated. The typical alterations induced by a portacaval shunt constitute the best demonstration of the …
Continue reading at pmc.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins

Similar Documents

Publication Publication Date Title
Francavilla et al. Regulation of liver size and regeneration: importance in liver transplantation
Starzl et al. The effect of splanchnic viscera removal upon canine liver regeneration
Rooman et al. Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan
SAR et al. Nuclear Concentration of Androgens in Rat Seminal Vesicles and Prostate Demonstrated by Dry-Mount Autoradiography1
Terblanche et al. Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver
Starzl et al. Hepatotrophic effects of FK506 in dogs
Kinson et al. Diurnal variation in plasma testosterone of the male laboratory rat
Nyholm et al. Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus
Starzl et al. The effect upon the liver of evisceration with or without hormone replacement
Benn et al. Metabolic effects of an insulin‐like factor causing hypoglycaemia in a patient with a haemangiopericytoma
Lambotte et al. Control of rate and extent of the proliferative response after partial hepatectomy
Feng et al. Therapeutic effects of resveratrol liposome on muscle injury in rats
Geraci et al. Amelioration of radiation nephropathy in rats by dexamethasone treatment after irradiation
Francavilla et al. FK 506 as a growth control factor
Van Zyl Note on the effects of thyroidectomy and thyroid hormone administration on the concentration of bile cholesterol and cholic acid
Piazza et al. Hepatitis B antigen inhibitor in human faeces and intestinal mucosa
Francavilla et al. Effect on the canine Eck fistula liver of intraportal TGF‐β alone or with hepatic growth factors
Malatesta et al. Hypometabolic induced state: a potential tool in biomedicine and space exploration
DIETRICH et al. In vitro effects of ionophore A23187 on skeletal collagen and noncollagen protein synthesis
Mazzaferro et al. Studies of the hepatotrophic qualities of FK 506 and CyA
Soliman et al. Levels of thyroid and thyrotrophic hormones in the blood of rats at various stages of the oestrous cycle
Azzarone et al. Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1
Rouiller et al. Release of somatostatin-like immunoreactivity from the lower gut
Copeland et al. Effect of mammalian insulin on plasma glucose in the mud puppy (Necturus maculosus)
Gadelha et al. Is parathyroid allotransplantation a viable option in the treatment of permanent hypoparathyroidism? A review of the literature